Balyasny Asset Management Portfolio holdings
AUM
$44B
1-Year Return
17.37%
This Quarter Return
-0.7%
1 Year Return
+17.37%
3 Year Return
+72.12%
5 Year Return
+152.69%
10 Year Return
+378.29%
AUM
$39.9B
AUM Growth
-$3.06B
(-7.1%)
Cap. Flow
-$2.28B
Cap. Flow
% of AUM
-5.71%
Top 10 Holdings %
Top 10 Hldgs %
11.13%
Holding
2,532
New
591
Increased
715
Reduced
610
Closed
508
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$484M |
| 2 |
Mastercard
MA
|
+$407M |
| 3 |
Charles Schwab
SCHW
|
+$400M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$287M |
| 5 |
Intuit
INTU
|
+$283M |
Top Sells
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$455M |
| 2 |
Coca-Cola
KO
|
+$423M |
| 3 |
Starbucks
SBUX
|
+$330M |
| 4 |
Salesforce
CRM
|
+$303M |
| 5 |
PNC Financial Services
PNC
|
+$274M |
Sector Composition
| 1 | Technology | 15.69% |
| 2 | Financials | 14.96% |
| 3 | Consumer Discretionary | 13.59% |
| 4 | Industrials | 10.73% |
| 5 | Healthcare | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONC
1076
BeOne Medicines Ltd. American Depositary Shares
ONC
$36B
| $2.47M | ﹤0.01% |
9,064
-35,229
| -80% | -$9.59M |
|
1077
The Oncology Institute
TOI
$283M
| $2.45M | ﹤0.01% |
2,147,332
+421,770
| +24% | +$481K |
|
1078
89bio
ETNB
$1.22B
| $2.45M | ﹤0.01% |
336,649
-682,800
| -67% | -$4.96M |
|
1079
Scansource
SCSC
$980M
| $2.44M | ﹤0.01% |
71,682
+60,708
| +553% | +$2.06M |
|
1080
Vanguard Growth ETF
VUG
$190B
| $2.44M | ﹤0.01% |
+6,570
| New | +$2.44M |
|
1081
Constellation Brands
STZ
$24.7B
| $2.43M | ﹤0.01% |
13,240
+3,636
| +38% | +$667K |
|
1082
Intuitive Machines
LUNR
$1.05B
| $2.41M | ﹤0.01% |
+324,060
| New | +$2.41M |
|
1083
Oaktree Specialty Lending
OCSL
$1.22B
| $2.41M | ﹤0.01% |
156,996
-1,028,154
| -87% | -$15.8M |
|
1084
Adient
ADNT
$1.96B
| $2.41M | ﹤0.01% |
+187,188
| New | +$2.41M |
|
1085
Newell Brands
NWL
$2.49B
| $2.4M | ﹤0.01% |
+387,525
| New | +$2.4M |
|
1086
Wolfspeed
WOLF
$344M
| $2.4M | ﹤0.01% |
+782,713
| New | +$2.4M |
|
1087
Petco
WOOF
$981M
| $2.39M | ﹤0.01% |
784,791
-892,436
| -53% | -$2.72M |
|
1088
Akebia Therapeutics
AKBA
$777M
| $2.39M | ﹤0.01% |
1,245,494
+971,042
| +354% | +$1.86M |
|
1089
Twist Bioscience
TWST
$1.53B
| $2.39M | ﹤0.01% |
+60,760
| New | +$2.39M |
|
1090
Mirion Technologies
MIR
$5.2B
| $2.38M | ﹤0.01% |
164,032
+127,530
| +349% | +$1.85M |
|
1091
Mineralys Therapeutics
MLYS
$2.83B
| $2.37M | ﹤0.01% |
149,273
+131,487
| +739% | +$2.09M |
|
1092
Rocket Pharmaceuticals
RCKT
$340M
| $2.35M | ﹤0.01% |
+352,957
| New | +$2.35M |
|
1093
Datadog
DDOG
$47.9B
| $2.35M | ﹤0.01% |
+23,672
| New | +$2.35M |
|
1094
Revolve Group
RVLV
$1.61B
| $2.33M | ﹤0.01% |
108,481
-687,126
| -86% | -$14.8M |
|
1095
John B. Sanfilippo & Son
JBSS
$741M
| $2.33M | ﹤0.01% |
32,840
+13,998
| +74% | +$992K |
|
1096
Energy Services of America
ESOA
$170M
| $2.33M | ﹤0.01% |
246,149
+223,444
| +984% | +$2.11M |
|
1097
Ambarella
AMBA
$3.44B
| $2.33M | ﹤0.01% |
46,200
-584,307
| -93% | -$29.4M |
|
|
PENG
1098
Penguin Solutions, Inc. Ordinary Shares
PENG
$1.37B
| $2.32M | ﹤0.01% |
133,738
-22,064
| -14% | -$383K |
|
1099
Solid Biosciences
SLDB
$422M
| $2.32M | ﹤0.01% |
+627,274
| New | +$2.32M |
|
|
TRTX
1100
TPG RE Finance Trust
TRTX
$742M
| $2.32M | ﹤0.01% |
+284,470
| New | +$2.32M |
|